Project Papers

Autologous tolerogenic dendritic cells for rheumatoid and inflammatory arthritis PDF 546Kb

Bell GM, Anderson AE, Diboll J, Reece R, Eltherington O, Harry RA, Fouweather T, MacDonald C, Chadwick T, McColl E, Dunn J, Dickinson AM, Hilkens CM, Isaacs JD. Annals of the Rheumatic Diseases, 26 Apr 2016, 76(1):227-234.

https://doi.org/10.1136/annrheumdis-2015-208456 PMID: 27117700 PMCID: PMC5264217

Isaacs J. SP0087 How antigen presenting cells can be turned into tolerogenic cells. Annals of the Rheumatic Diseases 2017;76:22. http://dx.doi.org/10.1136/annrheumdis-2017-eular.7253

Hilkens CMU, Isaacs JD. Tolerogenic dendritic cell therapy for rheumatoid arthritis: where are we now?. Clinical and Experimental Immunology 2013 May;172(2):148–157. https://doi.org/10.1111/cei.12038

Swift J, Stanway J, Hilkens C, et al. OP0129 AUTOREACTIVE, CITRULLINATED PEPTIDE-SPECIFIC T CELLS IN RHEUMATOID ARTHRITIS. Annals of the Rheumatic Diseases 2020;79:84-85. http://dx.doi.org/10.1136/annrheumdis-2020-eular.4687